Abstract
The ‘vanishing bone’ syndrome multicentric osteolysis with nodulosis and arthropathy (MONA) is a rare chronic skeleton disorder caused by matrix metalloproteinase 2 (MMP2) deficiency, mimicking erosive polyarticular juvenile idiopathic arthritis. MONA is characterised by facial dysmorphism, subcutaneous fibrocollagenous nodules, carpal and tarsal osteolysis and interphalangeal joint erosions. We present the case of a 5-year-old boy with double outlet right ventricle, ventricular septal defect, coarctation of the aorta and MONA. Previously, a total of 24 cases of MONA have been reported of which six also had congenital cardiac malformations. Despite treatment attempts of our patient with methotrexate, eternacept and prednisolone, serial X-ray studies documented continuous severe bone degeneration. Conclusion: The case documents the natural history of MONA and establishes a link between MMP2 deficiency and heart development, and given the recurring cardiac association, we suggest that all MONA patients be examined for possible cardiac defects.
Similar content being viewed by others
Abbreviations
- DNA:
-
Deoxyribonucleic acid.
- JIA:
-
Juvenile idiopathic arthritis.
- MIM:
-
Mendelian inheritance in man
- MMP2:
-
Matrix metalloproteinase 2
- MONA:
-
Multicentric osteolysis with nodulosis and arthropathy
- SDS:
-
Standard deviation score
References
Al Aqeel A, Al Sewairi W, Edress B, Gorlin RJ, Desnick RJ, Martignetti JA (2000) Inherited multicentric osteolysis with arthritis: a variant resembling Torg syndrome in a Saudi family. Am J Med Genet 93(1):11–18
Al-Mayouf SM, Majeed M, Hugosson C, Bahabri S (2000) New form of idiopathic osteolysis: nodulosis, arthropathy and osteolysis (NAO) syndrome. Am J Med Genet 93(1):5–10
Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Reiter RJ (2007) Relation of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction. Thromb Res 120(3):361–366. doi:10.1016/j.thromres.2006.10.010
Dominguez-Rodriguez A, Kaski JC, Abreu-Gonzalez P, Garcia-Gonzalez MJ (2008) The kinetics of metalloproteinase-9: the significance of the light–dark cycle in metalloproteinase-9 in acute coronary syndrome. Rev Esp Cardiol 61(3):327–328, author reply
Evans BR, Mosig RA, Lobl M, Martignetti CR, Camacho C, Grum-Tokars V, Glucksman MJ, Martignetti JA (2012) Mutation of membrane type-1 metalloproteinase, MT1-MMP, causes the multicentric osteolysis and arthritis disease Winchester syndrome. Am J Hum Genet 91(3):572–576. doi:10.1016/j.ajhg.2012.07.022
Gok F, Crettol LM, Alanay Y, Hacihamdioglu B, Kocaoglu M, Bonafe L, Ozen S (2010) Clinical and radiographic findings in two brothers affected with a novel mutation in matrix metalloproteinase 2 gene. Eur J Pediatr 169(3):363–367. doi:10.1007/s00431-009-1028-7
Jeong SY, Kim BY, Kim HJ, Yang JA, Kim OH (2010) A novel homozygous MMP2 mutation in a patient with Torg–Winchester syndrome. J Hum Genet 55(11):764–766. doi:10.1038/jhg.2010.102
Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, Mayouf SA, Sheth KV, Eid WA, Dowling O, Harris J, Glucksman MJ, Bahabri S, Meyer BF, Desnick RJ (2001) Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 28(3):261–265. doi:10.1038/90100
Mosig RA, Dowling O, DiFeo A, Ramirez MC, Parker IC, Abe E, Diouri J, Aqeel AA, Wylie JD, Oblander SA, Madri J, Bianco P, Apte SS, Zaidi M, Doty SB, Majeska RJ, Schaffler MB, Martignetti JA (2007) Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum Mol Genet 16(9):1113–1123. doi:10.1093/hmg/ddm060
Rouzier C, Vanatka R, Bannwarth S, Philip N, Coussement A, Paquis-Flucklinger V, Lambert JC (2006) A novel homozygous MMP2 mutation in a family with Winchester syndrome. Clin Genet 69(3):271–276. doi:10.1111/j.1399-0004.2006.00584.x
Rowinsky EK, Humphrey R, Hammond LA, Aylesworth C, Smetzer L, Hidalgo M, Morrow M, Smith L, Garner A, Sorensen JM, Von Hoff DD, Eckhardt SG (2000) Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12–9566 on a protracted oral daily dosing schedule in patients with solid malignancies. J Clin Oncol: Off J Am Soc Clin Oncol 18(1):178–186
Temtamy SA, Ismail S, Aglan MS, Ashour AM, Hosny LA, El-Badry TH, Aboul-Ezz EH, Amr K, Fateen E, Maguire T, Ungerer K, Zankl A (2012) A report of three patients with MMP2 associated hereditary osteolysis. Genet Couns 23(2):175–184
Tuysuz B, Mosig R, Altun G, Sancak S, Glucksman MJ, Martignetti JA (2009) A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects. Eur J Hum Genet : EJHG 17(5):565–572. doi:10.1038/ejhg.2008.204
Warman ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, LeMerrer M, Mortier G, Mundlos S, Nishimura G, Rimoin DL, Robertson S, Savarirayan R, Sillence D, Spranger J, Unger S, Zabel B, Superti-Furga A (2011) Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet Part A 155A(5):943–968. doi:10.1002/ajmg.a.33909
Wojtowicz-Praga S, Torri J, Johnson M, Steen V, Marshall J, Ness E, Dickson R, Sale M, Rasmussen HS, Chiodo TA, Hawkins MJ (1998) Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. J Clin Oncol : Off J Am Soc Clin Oncol 16(6):2150–2156
Zankl A, Bonafe L, Calcaterra V, Di Rocco M, Superti-Furga A (2005) Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2. Clin Genet 67(3):261–266. doi:10.1111/j.1399-0004.2004.00402.x
Zankl A, Pachman L, Poznanski A, Bonafe L, Wang F, Shusterman Y, Fishman DA, Superti-Furga A (2007) Torg syndrome is caused by inactivating mutations in MMP2 and is allelic to NAO and Winchester syndrome. J Bone Miner Res : the Off J Am Soc Bone Miner Res 22(2):329–333. doi:10.1359/jbmr.061013
Conflict of interest
The authors declare that they have no conflict of interest.
Consent
The authors have received parental consent to report relevant clinical information and publish images of the patient.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Castberg, F.C., Kjaergaard, S., Mosig, R.A. et al. Multicentric osteolysis with nodulosis and arthropathy (MONA) with cardiac malformation, mimicking polyarticular juvenile idiopathic arthritis: case report and literature review. Eur J Pediatr 172, 1657–1663 (2013). https://doi.org/10.1007/s00431-013-2102-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-013-2102-8